TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05723952

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Barcelona scoliosis physical therapy school
Description: procedure for treating Adolescent Idiopathic scoliosis

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: International scoliosis schroth therapy
Description: procedure for treating Adolescent Idiopathic scoliosis
Study: NCT05667818

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine besylate tablets (trade name: Norfloxacin ®）
Description: Specification: 5 mg Batch No.: FX3445 Content: 100.2% Expiry date: January 2027 Storage conditions: dark and sealed Manufacturer: Pfizer Inc. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate controlled-release tablets
Description: Test preparation (T): amlodipine besylate controlled-release tablets Specification: 5 mg Batch No.: 22102501 Content: 100.9% Expiry date: October 24, 2024 Storage conditions: dark, sealed at room temperature. Manufacturer: Overseas Pharmaceuticals, Ltd. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.
Study: NCT06307834

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback - based therapy
Description: This intervention will include mental practice of various hand movements accompanied by guided visual feedback, aimed at regulating brain activation patterns to facilitate the restoration of hand movements. We will also incorporate EMG signals to control a hand exoskeleton.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard hand exercise therapy
Description: This intervention will include engaging in a set of particular hand exercises with the aim of enhancing hand movements.
Study: NCT05034835

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: usual treatment with compression garments (CERECARE)
Description: For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.

Intervention type: OTHER
Group type: OTHER
Intervention: usual treatment without compression garments (CERECARE)
Description: For 3 months, the pain will be assessed every week, tolerance and compliance with compression garments will also be monitored. Participants will be reviewed specifically at a follow-up consultation for the 6-month and 1-year study. Various assessments will be carried out during these visits : assessment of pain, range of motion, muscle strength, sensitivity test, assessment of anxiety, depression and even quality of life.
Study: NCT04923880

Intervention type: OTHER
Group type: OTHER
Intervention: Implementation of Primary Palliative Care Intervention in CF Centers
Description: Individuals with CF ages 12 years and above will complete an annual palliative care needs assessment with the CF care team using the IPOS (Integrated Palliative Care Outcome Scale).~Individuals with CF under 12 years of age will complete an annual palliative care needs assessment with the CF care team using IPOS as a conversation guide.~Caregivers of Individuals with CF of all ages will be offered the BASC (Brief Assessment Scale for Caregivers).~In addition to annual needs assessment, palliative care needs assessment will take place when triggered by changes in disease status, such as hospitalization, new diagnosis of CF related Diabetes or referral to transplant.
Study: NCT05835271

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: exoskeleton assist
Description: A powered exoskeleton describes a wearable robot designed around the shape and function of the human body with segments and joints externally coupled to those of the user. The exoskeleton includes a rigid outer frame, sensors that detect a user's desired movements, a computerized controller, motors and actuators, and lightweight batteries.~The exoskeleton is designed to be worn in the community.
Study: NCT06146777

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion
Study: NCT05208359

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Supporting Transition Resilience Of Newcomer Groups (STRONG)
Description: 10 group sessions that offer skills, strengths, support, and affirmation for newcomer youth

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supporting Transition Resilience Of Newcomer Groups (STRONG)
Description: 10 group sessions that offer skills, strengths, support, and affirmation for newcomer youth
Study: NCT04879212

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PCIA +Acupuncture group:
Description: Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PCIA +Acupuncture group:
Description: Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PCIA +Acupuncture group:
Description: Acupuncturing bilateral Zusanli (ST36) and Sanyinjiao (SP6)
Study: NCT06085053

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQA3038 injection
Description: TQA3038 is an injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQA3038 injection matching placebo
Description: Placebo injection contains no active substance.
Study: NCT05656755

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strengthening
Description: The strengthening exercises were executed with the body weight without any additional weight and were composed of exercises like the squats, the lunges, the plank, and the mountain climbers

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Running
Description: running for two supervised training sessions of one hour, and one free session of 30 minutes per week during 24 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Running
Description: running for two supervised training sessions of one hour, and one free session of 30 minutes per week during 24 weeks
Study: NCT05828004

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Whole-Course Multidisciplinary Care Intervention
Description: On the basis of standard treatment, all patients were evaluated by senior practice nurses in the Department of Oncology in person at the time of enrollment (before radiotherapy) and once every week during radiotherapy, and once in person/over the phone at 1, 2, 3, and 6 months after radiotherapy.
Study: NCT05726513

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Weaning trial - Low support, high Positive end-expiratory pressure
Description: The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with low pressure support ventilation and a positive end expiratory pressure of 5 cmH2O

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Weaning trial - Low support, zero positive end-expiratory pressure
Description: The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with low pressure support ventilation and a positive end expiratory pressure of 0 cmH2O

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Weaning trial - Zero support, zero positive end-expiratory pressure
Description: The researcher will evaluate the readiness to be weaned of the patient using a weaning trial with 0 pressure support ventilation and a positive end expiratory pressure of 0 cmH2O
Study: NCT05012774

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech Recognition Training
Description: Training for each training arm takes place over 10 sessions carried out at home. on the participant's own computer without experimenter direct supervision. Pre- and post-training tests are carried out under experimenter supervision.
Study: NCT05895643

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide Injectable Product
Description: Once weekly injections s.c with semaglutide (Wegovy)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once weekly injections s.c with placebo (BD Posiflush)
Study: NCT05350813

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Measurement of the PCT plasma levels
Description: antibiotic treatment duration will be based on PCT plasma levels

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual practice based on guidelines
Description: antibiotic therapy duration will be determined by the type of infection, microbiological results and clinical, biological and/or radiological evolution, according to the usual practice based on guidelines.
Study: NCT05522946

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gameplay between parent and child or adolescent with or without a disability
Description: Parent and child or adolescent will play the game using the provided sensors for 10-15 minutes total. Depending on the cognitive and/or physical ability of the child or adolescent, the two may take turns wearing the sensors or if the child or adolescent does not have the physical or cognitive ability to deliberately touch the sensor, then the child or adolescent will wear the sensors and the parent will touch the sensors in order to move the game forward.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gameplay between parent and child or adolescent with or without a disability
Description: Parent and child or adolescent will play the game using the provided sensors for 10-15 minutes total. Depending on the cognitive and/or physical ability of the child or adolescent, the two may take turns wearing the sensors or if the child or adolescent does not have the physical or cognitive ability to deliberately touch the sensor, then the child or adolescent will wear the sensors and the parent will touch the sensors in order to move the game forward.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gameplay between parent and child or adolescent with or without a disability
Description: Parent and child or adolescent will play the game using the provided sensors for 10-15 minutes total. Depending on the cognitive and/or physical ability of the child or adolescent, the two may take turns wearing the sensors or if the child or adolescent does not have the physical or cognitive ability to deliberately touch the sensor, then the child or adolescent will wear the sensors and the parent will touch the sensors in order to move the game forward.
Study: NCT04489732

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous bone-marrow derived, interferon gamma stimulated mesenchymal stromal cells
Description: Single dose, starting at~* Dose Level 0: 10 (8-12) x 10\^6 injected into one submandibular gland on Day 1~Sub-study for second injection after primary objectives met, 10 (8 - 12) x 10\^6 MSCs will be offered for injection into each participant's contralateral submandibular gland
Study: NCT04747223

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Run Gait Retraining
Description: Running step rate will be retrained by real-time biofeedback via a watch accelerometer. Recent literature showed that performing gait retraining by altering step rate reduces loading rates and joint stress that are associated with lower extremity injuries (Wilson et al 2014, Lenhart et al 2014, Heidersheit et al 2011).
Study: NCT05160298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0,2% Injectable Solution
Description: Echo-guided bilateral erector spinae block

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Sham block
Study: NCT06044506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous Natural Killer Cell Therapy
Description: The therapy will be administered intravenously

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clinimacs Plus
Description: The CliniMACS Plus device is an automated cell separation tool that uses MACS Technology. It incorporates a flexible system designed for isolating clinically labeled cells using MicroBeads.
Study: NCT05629299

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Samples
Description: Men will give semen, saliva, skin, urine and blood specimens
Study: NCT06456476

Intervention type: DIAGNOSTIC_TEST
Intervention: ERCP
Description: ERCP used only if needed in some patients
Study: NCT06216652

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: downhill walking
Description: All participants received a conventional physiotherapy program for 2 days/week, 40 min/day for 8 weeks. In addition to this program, the first group performed downhill walking exercise on the treadmill for 2 days/week, 30 min/day on different days.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: uphill walking
Description: All participants received a conventional physiotherapy program for 2 days/week, 40 min/day for 8 weeks. In addition to this program, the second group performed uphill walking exercise on the treadmill for 2 days/week, 30 min/day on different days.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: walking with no incline
Description: All participants received a conventional physiotherapy program for 2 days/week, 40 min/day for 8 weeks. In addition to this program, the third group performed walking with no incline walking exercise on the treadmill for 2 days/week, 30 min/day on different days.
Study: NCT05444634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Distraction Card
Description: Suitable for children over 3 years old. 1 set of 32 pieces of thick cardboard cards It has been prepared by child development experts in line with pedagogical principles.~Size: 13cm x 8cm, Each card illustrates the skills and actions the children do.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Ball
Description: Brain Shaped Stress Ball, White rope in the form of mesh around the inner silicone Size: Approx 2.4 inches (6 cm), Color: Colorful, When squeezed, the silicone structure comes out in the mesh spaces and turns into a bunch of grapes.
Study: NCT04681053

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Powder
Description: - Administration through inhalation (6mg) BID for 3 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Powder
Description: - Administration through inhalation (6mg) BID for 3 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Powder
Description: - Administration through inhalation (6mg) BID for 3 days
Study: NCT05184322

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily for 15 days.
Study: NCT06377332

Intervention type: OTHER
Intervention: Cognitive Assessment
Description: The following cognitive assessments will be administered using a digital format on CANTAB:~1. Motor Screening Task (MOT) Used to assess sensorimotor function and comprehension and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease. This task acts as a practice trial for the subsequent tasks.~2. Reaction Time (RTI) Used to assess processing and psychomotor speed and is applicable in the assessment of general cognitive function and Alzheimer's disease.~3. Paired Associate Learning (PAL) Used to assess visual episodic memory and is applicable in the assessment of general cognitive function, Alzheimer's disease, Parkinson's disease and cerebrovascular disease.~4. Spatial Working Memory (SWM) Used to assess working memory and strategy and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease.

Intervention type: OTHER
Intervention: Cognitive Assessment
Description: The following cognitive assessments will be administered using a digital format on CANTAB:~1. Motor Screening Task (MOT) Used to assess sensorimotor function and comprehension and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease. This task acts as a practice trial for the subsequent tasks.~2. Reaction Time (RTI) Used to assess processing and psychomotor speed and is applicable in the assessment of general cognitive function and Alzheimer's disease.~3. Paired Associate Learning (PAL) Used to assess visual episodic memory and is applicable in the assessment of general cognitive function, Alzheimer's disease, Parkinson's disease and cerebrovascular disease.~4. Spatial Working Memory (SWM) Used to assess working memory and strategy and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease.

Intervention type: OTHER
Intervention: Cognitive Assessment
Description: The following cognitive assessments will be administered using a digital format on CANTAB:~1. Motor Screening Task (MOT) Used to assess sensorimotor function and comprehension and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease. This task acts as a practice trial for the subsequent tasks.~2. Reaction Time (RTI) Used to assess processing and psychomotor speed and is applicable in the assessment of general cognitive function and Alzheimer's disease.~3. Paired Associate Learning (PAL) Used to assess visual episodic memory and is applicable in the assessment of general cognitive function, Alzheimer's disease, Parkinson's disease and cerebrovascular disease.~4. Spatial Working Memory (SWM) Used to assess working memory and strategy and is applicable in the assessment of general cognitive function, Alzheimer's disease and cerebrovascular disease.
Study: NCT05184322

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily for 6 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily and titrated up in concentration to once every week during maintenance period.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ecnoglutide tablet
Description: Once daily for 15 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily for 6 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Once daily for 6 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T2026
Description: Once daily to once weekly for 12 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Once daily to once weekly for 12 weeks.